Pharmaceutical company, Intravenous Infusions PLC, has announced an increase in revenue of 9.6 percent for the 2021 financial year. According to the company, the growth in revenue resulted in a profit before tax of 1.4 million cedis, compared to 1.3 million cedis recorded in 2020. Speaking at the company’s Annual General Meeting (AGM), the Board … Continue reading Intravenous Infusions announces increase in revenue of 9.6% for 2021 financial year